By:
On:
In: International News
With: 0 Comments

A research was done on the effectiveness of Pfizer Covid-19 vaccine among children. (REUTERS/Dado Ruvic/Illustration)Researchers from the New York State Department of Health and the University at Albany School of Public Health, US, estimated the effectiveness of Pfizer vaccine against Covid cases and hospitalisations.PTI WashingtonLast Updated:March 01, 2022, 19:32 ISTFOLLOW US ON:The effectiveness of the…Continue Reading

By:
On:
In: International News
With: 0 Comments

India’s Covid inoculation programme is largely driven by Indian made vaccines. Even though Russia’s Sputnik and Johnson & Johnson’s single-dose vaccine were given a go-ahead by the Indian drug regulatory authority, it was Indian made Covaxin and Covishield that was widely used under the government-run vaccine programme. But it begs the question as to why…Continue Reading

Pfizer may offer Covid antiviral drug to India at lower price for now

By:
On:
In: International News
With: 0 Comments

SynopsisPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use authorisation in India. may offer its Covid antiviral drug Paxlovid at lower prices for low and middle income countries (LMICs), including India, as an interim measure as the cheaper generic versions may not…Continue Reading

Pfizer Says Its Covid Pill Near 90% Effective in Final Analysis; Lab Data Shows Drug Works Against Omicron

By:
On:
In: International News
With: 0 Comments

Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients. (Image: AP Photo/Mark Lennihan/File)The US drugmaker last month said the oral medicine was around 89% effective in preventing hospitalisations or deaths when compared to placebo.Reuters Last Updated:December 14, 2021, 17:55 ISTFOLLOW US ON:Pfizer Inc on Tuesday said the…Continue Reading

Booster Shot of Pfizer Covid Vaccine Can Cut Mortality from Delta Variant by 90%: Study

By:
On:
In: International News
With: 0 Comments

A total of 843,208 participants met the eligibility criteria, of whom 758,118 (90 per cent) received the booster during the 54-day study period (File photo: Reuters) The research included data from participants 50 years of age or older who had received two doses of Pfizer vaccine at least five months earlier.PTI JerusalemLast Updated:December 10, 2021,…Continue Reading